Welcome to LookChem.com Sign In|Join Free
  • or
4(3H)-Quinazolinone, 3-[(4-bromophenyl)methyl]-6-nitro-2-propyl- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

156483-24-8

Post Buying Request

156483-24-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

156483-24-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 156483-24-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,6,4,8 and 3 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 156483-24:
(8*1)+(7*5)+(6*6)+(5*4)+(4*8)+(3*3)+(2*2)+(1*4)=148
148 % 10 = 8
So 156483-24-8 is a valid CAS Registry Number.

156483-24-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-(4-bromobenzyl)-6-nitro-2-propyl-3,4-dihydroquinazolin-4-one

1.2 Other means of identification

Product number -
Other names 3-(4-Bromo-benzyl)-6-nitro-2-propyl-3H-quinazolin-4-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:156483-24-8 SDS

156483-24-8Downstream Products

156483-24-8Relevant academic research and scientific papers

The design, binding affinity prediction and synthesis of macrocyclic angiotensin II AT1 and AT2 receptor antagonists

De Laszlo, Stephen E.,Glinka, Tomasz W.,Greenlee, William J.,Ball, Richard,Nachbar, Robert B.,Prendergast, Kristine

, p. 923 - 928 (1996)

Analysis of the SAR of AT1 selective and AT1/AT2 balanced affinity angiotensin II antagonists led to the design of macrocyclic quinazolinone ligands. CoMFA analysis was used to predict the binding affinities of these novel ligands. The synthesis, X-ray crystal structure, binding affinity and the relevance of these studies to the determination of the biologically relevant binding conformation is discussed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 156483-24-8